Literature DB >> 30297326

Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis.

Ye Ji Lee1, Samuel Bitoun2, Jin Kyun Park1, Kevin L Winthrop3, Yunhee Choi4, Eun Bong Lee1, Xavier Mariette5.   

Abstract

Entities:  

Keywords:  BAFF; methotrexate; rheumatoid arthritis; vaccination

Mesh：

Substances：

Year:  2018        PMID： 30297326     DOI： 10.1136/annrheumdis-2018-214025

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  COVID-19 vaccination in immunocompromised patients.

Authors:  Bhavin Sonani; Fawad Aslam; Amandeep Goyal; Janki Patel; Pankaj Bansal
Journal:  Clin Rheumatol       Date:  2021-01-11       Impact factor: 2.980

Review 2.  A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review.

Authors:  Mehmet Soy; Gökhan Keser; Pamir Atagunduz; Melek Yalçin Mutlu; Alper Gunduz; Gizem Koybaşi; Cemal Bes
Journal:  Clin Rheumatol       Date:  2021-03-22       Impact factor: 2.980

Review 3.  Immunosuppression in Glomerular Diseases: Implications for SARS-CoV-2 Vaccines and COVID-19.

Authors:  Michael R Yeaman
Journal:  Glomerular Dis       Date:  2021-08-25

Review 4.  Coronavirus disease 2019 (Covid-19) vaccination recommendations in special populations and patients with existing comorbidities.

Authors:  Zeinab Mohseni Afshar; Arefeh Babazadeh; Alireza Janbakhsh; Feizollah Mansouri; Terence T Sio; Mark J M Sullman; Kristin Carson-Chahhoud; Rezvan Hosseinzadeh; Mohammad Barary; Soheil Ebrahimpour
Journal:  Rev Med Virol       Date:  2021-10-22       Impact factor: 11.043

5.  SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study.

Authors:  Alexandra Dopfer-Jablonka; Sandra Steffens; Frank Müller; Tobias R Overbeck; Stephanie Heinemann; Marie Mikuteit; Jacqueline Niewolik; Anne Cossmann; Metodi V Stankov; Georg M N Behrens; Eva Hummers; Gloria Heesen; Dominik Schröder; Sascha Roder; Frank Klawonn; Kai Vahldiek; Justin Hasenkamp; Jonathan Kallusky; Christine S Falk
Journal:  BMC Infect Dis       Date:  2022-04-25       Impact factor: 3.667

6.  Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study).

Authors:  Abhishek Abhishek; R J Boyton; Áine McKnight; Laura Coates; James Bluett; Vicki S Barber; Lucy Cureton; Anne Francis; Duncan Appelbe; Lucy Eldridge; Patrick Julier; Nicholas Peckham; Ana M Valdes; Ines Rombach; Daniel M Altmann; Jonathan Nguyen-Van-Tam; Hywel C Williams; Jonathan Alistair Cook
Journal:  BMJ Open       Date:  2022-05-03       Impact factor: 3.006

7.  Methotrexate Treatment Suppresses Monocytes in Nonresponders to Pneumococcal Conjugate Vaccine in Rheumatoid Arthritis Patients.

Authors:  Evelina Elmér; Per Nived; Åsa Pettersson; Lillemor Skattum; Thomas Hellmark; Meliha C Kapetanovic; Åsa C M Johansson
Journal:  J Immunol Res       Date:  2022-07-28       Impact factor: 4.493

8.  CD47 Potentiates Inflammatory Response in Systemic Lupus Erythematosus.

Authors:  Jin Kyun Park; Ye Ji Lee; Ji Soo Park; Eun Bong Lee; Yeong Wook Song
Journal:  Cells       Date:  2021-05-10       Impact factor: 6.600
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.